The historical rank and industry rank for Japan Medical Dynamic Marketing's Return-on-Tangible-Equity or its related term are showing as below:
FRA:JMD'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -1.86 Med: 9.6 Max: 14.1
Current: 1.08
During the past 13 years, Japan Medical Dynamic Marketing's highest Return-on-Tangible-Equity was 14.10%. The lowest was -1.86%. And the median was 9.60%.
FRA:JMD's Return-on-Tangible-Equity is ranked worse than 57.28% of 756
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs FRA:JMD: 1.08
Japan Medical Dynamic Marketing (FRA:JMD) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Japan Medical Dynamic Marketing Return-on-Tangible-Equity Related Terms
Japan Medical Dynamic Marketing Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Medical Dynamic Marketing Return-on-Tangible-Equity Chart
FRA:JMD vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Japan Medical Dynamic Marketing's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Medical Dynamic Marketing Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Japan Medical Dynamic Marketing's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -0.39% mean?
Japan Medical Dynamic Marketing (FRA:JMD) has a Return-on-Tangible-Equity of -0.39% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Japan Medical Dynamic Marketing and its competitors. According to the industry distribution chart, Japan Medical Dynamic Marketing ranks #433 out of 756 companies in the Medical Devices & Instruments industry, placing it in the top 57.3%.
Is Japan Medical Dynamic Marketing's Return-on-Tangible-Equity too high?
Japan Medical Dynamic Marketing's current Return-on-Tangible-Equity is -0.39%. Based on the distribution chart, Japan Medical Dynamic Marketing ranks #433 out of 756 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Medical Dynamic Marketing ranks #433 out of 756 companies for Return-on-Tangible-Equity. This places Japan Medical Dynamic Marketing in the lower half of its industry. The industry median Return-on-Tangible-Equity is 4.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Japan Medical Dynamic Marketing and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Medical Dynamic Marketing's current Return-on-Tangible-Equity is -0.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (FRA:JMD) has a current Return-on-Tangible-Equity of -0.39%. The stock's GF Value™ is €3.34, compared to a current price of €4.92 — trading 47.3% above its estimated fair value. The current Return-on-Tangible-Equity is -0.39%. Japan Medical Dynamic Marketing's overall GF Score™ is 77/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current Return-on-Tangible-Equity is -0.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued.
The current stock price of €4.92 is trading 47.3% above its estimated GF Value™ of €3.34.
Key valuation signals for FRA:JMD:
Return-on-Tangible-Equity: -0.39%
GF Value™: €3.34 vs. price of €4.92 (47.3% above fair value)
No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Medical Dynamic Marketing Business Description
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
77GF Score
Get the complete analysis for FRA:JMD
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:JMD has been successfully added to your 
